Expert Review Committee Member

Seema Sondhi

Seema Sondhi is a member of the 2026 Expert Review Committee for the Access to Medicine Index. With over three decades of experience in the pharmaceutical and medical devices industries, she has held senior roles in marketing, market access and pricing at global organisations including GSK, Baxter Healthcare and Takeda.

Most recently, Seema served as Head of Payer Value & Access for Takeda Vaccines, where she played a pivotal role in securing access for Takeda’s dengue vaccine across Latin America and Asia – notably enabling the fastest national vaccination programme rollout in Brazil. As Takeda’s Head of Global Pricing, she championed the introduction of tiered pricing, ensuring that low- and middle-income countries (LMICs) could access lifesaving medicines at more affordable rates. 

Seema has led market access strategies at the country, regional and global levels across pharmaceuticals, vaccines, medical devices and orphan drugs. She has worked closely with ministries of health and health technology assessment bodies worldwide to break down barriers and bring essential treatments to those in need. 

Seema holds a Bachelor of Science with Honours in Mathematics from the University of Southampton, along with a Health Economics Certificate and a Marketing Diploma.